Pharmacokinetic study of a combination chemo-endocrine treatment of paclitaxel and toremifene

被引：0
|
作者：
Saeki, T.
Okita, A.
Aogi, K.
Kakishita, T.
Okita, R.
Taira, N.
Takashima, S.
Fujita, K.
Nishikawa, K.
机构：
[1] Saitama Med Sch, Saitama, Japan
[2] Shikoku Canc Ctr, Matsuyama, Ehime, Japan
[3] Saitama Med Sch, Moroyama, Saitama, Japan
[4] Nippon Kayaku Co Ltd, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
13017
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A PHARMACOKINETIC STUDY OF ORAL PACLITAXEL IN COMBINATION WITH HM30181 IN SOLID CANCER PATIENTS
    Kim, S. E.
    Gu, N.
    Shin, D.
    Yoon, S. H.
    Cho, J. Y.
    Shin, S. G.
    Yu, K. S.
    Jang, I. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S36 - S36
  • [42] Postoperative adjuvant randomised trial comparing chemo-endocrine therapy, chemotherapy and immunotherapy for patients with stage II breast cancer: 5-year results from the Nishinihon cooperative study group of adjuvant chemo-endocrine therapy for breast cancer (ACETBC) of Japan (vol 32, pg 235, 1996)
    Morimoto
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (07) : 1264 - 1264
  • [43] Postoperative chemo-endocrine treatment with mitomycin C, tamoxifen, and UFT is effective for patients with premenopausal estrogen receptor-positive stage II breast cancer
    Sugimachi, K
    Maehara, Y
    Akazawa, K
    Nomura, Y
    Eida, K
    Ogawa, M
    Konaga, E
    Tanaka, N
    Toge, T
    Dohi, K
    Noda, S
    Maeda, M
    Monden, Y
    BREAST CANCER RESEARCH AND TREATMENT, 1999, 56 (02) : 113 - 124
  • [44] Ten-year results of a randomized trial on adjuvant chemo-endocrine therapy with tamoxifen for stage II breast cancer
    Yoshinobu Hata
    Hiromasa Takahashi
    Satoru Todo
    Minoru Okazaki
    Kazuaki Asaishi
    Koichi Hirata
    Shunichi Okushiba
    Hiroyuki Kato
    Junichi Uchino
    Breast Cancer, 2003, 10 (2) : 134 - 139
  • [45] p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer
    Ravaioli, A.
    Monti, F.
    Regan, M. M.
    Maffini, F.
    Mastropasqua, M. G.
    Spataro, V.
    Castiglione-Gertsch, M.
    Panzini, I.
    Gianni, L.
    Goldhirsch, A.
    Coates, A.
    Price, K. N.
    Gusterson, B. A.
    Viale, G.
    ANNALS OF ONCOLOGY, 2008, 19 (04) : 660 - 668
  • [46] Androgen Receptor Expression Is a Significant Prognostic Factor in Estrogen Receptor Positive Breast Cancers Treated with Chemo-Endocrine Therapy
    Castellano, I.
    Allia, E.
    Accortanzo, V.
    Vandone, A. M.
    Chiusa, L.
    Arisio, R.
    Durando, A.
    Donadio, M.
    Bussolati, G.
    Coates, A. S.
    Viale, G.
    Sapino, A.
    LABORATORY INVESTIGATION, 2010, 90 : 39A - 39A
  • [47] Androgen Receptor Expression Is a Significant Prognostic Factor in Estrogen Receptor Positive Breast Cancers Treated with Chemo-Endocrine Therapy
    Castellano, I.
    Allia, E.
    Accortanzo, V.
    Vandone, A. M.
    Chiusa, L.
    Arisio, R.
    Durando, A.
    Donadio, M.
    Bussolati, G.
    Coates, A. S.
    Viale, G.
    Sapino, A.
    MODERN PATHOLOGY, 2010, 23 : 39A - 39A
  • [48] Lack of correlation between menstrual phase during operation and prognosis of premenopausal patients with early breast cancer in a randomized study of adjuvant chemo-endocrine therapy
    Nomura, Y
    Takayama, T
    Hagino, Y
    Kataoka, A
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S26 - S26
  • [49] A phase I clinical and pharmacokinetic study of paclitaxel and docetaxel given in combination in patients with solid tumours
    Angel Izquierdo, Miguel
    Garcia, Margarita
    Luis Ponton, Jose
    Martinez, Marisa
    Valenti, Vicente
    Navarro, Matilde
    Gil, Miguel
    Cardenal, Felipe
    Mesia, Ricard
    Perez, Xavier
    Salazar, Ramon
    Ramon Germa-Lluch, Josep
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (12) : 1789 - 1796
  • [50] A phase I and pharmacokinetic study of bi-daily dosing of oral paclitaxel in combination with cyclosporin A
    Mirte M. Malingré
    Jos H. Beijnen
    Hilde Rosing
    Franciska J. Koopman
    Olaf van Tellingen
    Ken Duchin
    Wim W. Ten Bokkel Huinink
    Martha Swart
    Jan Lieverst
    Jan H.M. Schellens
    Cancer Chemotherapy and Pharmacology, 2001, 47 : 347 - 354
12345